RAPID MICRO BIOSYSTEMS, INC.(RPID)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,619 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
RPID Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for RAPID MICRO BIOSYSTEMS, INC. (RPID), a Technology sector company. 13F Pro's AI-powered ranking engine scores RPID at 26.5/100 on a 32-signal composite quality model, placing it at rank #2,619 of 2,962 stocks — the bottom half of the AI-ranked universe. RPID scores in the top quartile across institutional flow (92.1), revenue growth (82.6). Areas of concern include balance sheet strength (1.8) and free cash flow (6.2), which score below median versus the broader universe. Shareholder dilution risk is elevated at 14.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), RAPID MICRO BIOSYSTEMS, INC. reports quarterly revenue of $8.1M, net income of $-12.9M, free cash flow of $-12.9M. Top institutional holders of RPID by reported 13-F value include Bain Capital Life Sciences Investors, ARMISTICE CAPITAL, ABG-WTT Global Life Science Capital Partners GP Ltd, based on the most recent SEC filings. RPID trades on the Nasdaq exchange and files with the SEC under CIK 1380106. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate RPID daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for RAPID MICRO BIOSYSTEMS, INC. directly from SEC EDGAR. RAPID MICRO BIOSYSTEMS, INC.'s 13F Pro composite quality score has ranged between 7 and 30 since 2022, currently 26.5 — a declining long-term trajectory across 64 quarterly and live scoring snapshots.
Revenue
Q2 2026
$8.1M
Net Income
Q2 2026
$-12.9M
Free Cash Flow
Q2 2026
$-12.9M
D/E Ratio
Q2 2026
1.08
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+19.7% YoYNet Income
-0.5% YoYOperating Income
+5.1% YoYEPS (Diluted)
+2.8% YoYTotal Assets
-23.8% YoYTotal Debt
Op. Cash Flow
+29.6% YoYFree Cash Flow
+29.9% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $33.6M +19.7% | $28.1M +24.6% | $22.5M +31.4% | $17.1M -26.3% | $23.2M +44.5% | $16.1M |
| Net Income | $-47.1M -0.5% | $-46.9M +10.6% | $-52.5M +13.7% | $-60.8M +17.3% | $-73.5M -98.3% | $-37.1M |
| Operating Income | $-47.4M +5.1% | $-49.9M +11.7% | $-56.6M +10.5% | $-63.2M -33.8% | $-47.2M -54.7% | $-30.5M |
| EPS (Diluted) | $-1.05 +2.8% | $-1.08 +11.5% | $-1.22 +14.7% | $-1.43 +63.7% | $-3.94 +96.9% | $-126.11 |
| Total Assets | $74.9M -23.8% | $98.2M -31.6% | $143.5M -24.8% | $190.7M -20.9% | $241.2M +244.5% | $70.0M |
| Total Debt | $18.9M | $0.00 | — | $0.00 | $0.00 -100.0% | $24.8M |
| Operating Cash Flow | $-31.1M +29.6% | $-44.2M +2.1% | $-45.1M +23.0% | $-58.5M -6.5% | $-55.0M -77.3% | $-31.0M |
| Free Cash Flow | $-31.9M +29.9% | $-45.5M +3.0% | $-46.9M +28.1% | $-65.3M -12.2% | $-58.2M -83.6% | $-31.7M |
Get alerted when RPID's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for RAPID MICRO BIOSYSTEMS, INC. including:
Top Institutional Holders of RPID
Bain Capital Life Sciences Investors, LLC
$14.6M8,434,560 shARMISTICE CAPITAL, LLC
$5.8M3,328,000 shABG-WTT Global Life Science Capital Partners GP Ltd
$3.2M1,848,296 shVANGUARD CAPITAL MANAGEMENT LLC
$1.7M982,034 shEvernest Financial Advisors, LLC
$875.4K506,000 shADVENT INTERNATIONAL, L.P.
$657.0K379,794 shESSEX INVESTMENT MANAGEMENT CO LLC
$627.5K362,696 shMILLENNIUM MANAGEMENT LLC
$409.3K236,599 shGEODE CAPITAL MANAGEMENT, LLC
$394.7K228,041 shRENAISSANCE TECHNOLOGIES LLC
$366.9K212,101 sh
| Fund | Value | Shares |
|---|---|---|
| Bain Capital Life Sciences Investors, LLC | $14.6M | 8,434,560 |
| ARMISTICE CAPITAL, LLC | $5.8M | 3,328,000 |
| ABG-WTT Global Life Science Capital Partners GP Ltd | $3.2M | 1,848,296 |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.7M | 982,034 |
| Evernest Financial Advisors, LLC | $875.4K | 506,000 |
| ADVENT INTERNATIONAL, L.P. | $657.0K | 379,794 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $627.5K | 362,696 |
| MILLENNIUM MANAGEMENT LLC | $409.3K | 236,599 |
| GEODE CAPITAL MANAGEMENT, LLC | $394.7K | 228,041 |
| RENAISSANCE TECHNOLOGIES LLC | $366.9K | 212,101 |
Companies Similar to RPID
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
GSI TECHNOLOGY INC
AmpliTech Group, Inc.
RUM Group Inc.
D-Wave Quantum Inc.
LIGHTPATH TECHNOLOGIES INC
Rigetti Computing, Inc.
Silvaco Group, Inc.
Valens Semiconductor Ltd.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Technology Companies
View all Technology →Put RPID on your watchlist
Track score changes the day RAPID MICRO BIOSYSTEMS, INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is RPID a good stock to buy?
13F Pro's AI-powered analysis of RAPID MICRO BIOSYSTEMS, INC. (RPID) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for RPID are available on the RPID stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. RPID is classified as a small company.
Which hedge funds own RPID?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling RPID. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of RAPID MICRO BIOSYSTEMS, INC.'s investment landscape.